Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB2 in Healthy Subjects
Clinical trial NCT01922336 · COMPLETED
Trial details
- NCT number
- NCT01922336
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2013-10-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.